BAX

SEC source: 0001678065-17-000001 · edgar.xml · derivative · entry 1

Pleau Scott · CIK 0001678065 · CVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,781

Underlying: Common Stock,$1 par value · 42,781 shares

Expires 2027-03-02

F1 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the date of the grant.

SEC source: 0001645572-17-000002 · edgar.xml · derivative · entry 1

Eyre Brik V · CIK 0001645572 · CVP, Hospital Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,952

Underlying: Common Stock, $1 par value · 106,952 shares

Expires 2027-03-02

F1 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the date of the grant.

SEC source: 0001678067-17-000002 · edgar.xml · derivative · entry 1

Accogli Giuseppe · CIK 0001678067 · CVP, Renal

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,583

Underlying: Common Stock, $1 par value · 93,583 shares

Expires 2027-03-02

F1 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the date of the grant.

SEC source: 0000899243-17-005731 · doc4.xml · nonDerivative · entry 1

Third Point LLC · CIK 0001040273 · Director · See Remarks

Loeb Daniel S · CIK 0001300345 · Director · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 46,001,790

F1 · ownership.nature: Except as otherwise noted herein, the securities disclosed in this Form 4 are owned by certain funds (the "Funds") managed by Third Point LLC ("Third Point"). Daniel S. Loeb is the Chief Executive Officer of Third Point. By reason of the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, as amended, Third Point and Mr. Loeb may be deemed to be the beneficial owners of the securities beneficially owned by the Funds. Third Point and Mr. Loeb hereby disclaim beneficial ownership of all securities, except to the extent of any indirect pecuniary interest therein.

SEC source: 0001107468-17-000001 · edgar.xml · derivative · entry 4

HELLMAN PETER S · CIK 0001107468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock,$1 par value · 4,280 shares

Expires 2017-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001107468-17-000001 · edgar.xml · nonDerivative · entry 2

HELLMAN PETER S · CIK 0001107468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,140

SEC source: 0001107468-17-000001 · edgar.xml · nonDerivative · entry 1

HELLMAN PETER S · CIK 0001107468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,420

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001645277-17-000001 · edgar.xml · nonDerivative · entry 4

Vibert Paul · CIK 0001645277 · CVP, International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,914

F4 · kind: Represents shares earned from the performance share unit award granted on March 3, 2016 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on the Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2016 to December 31, 2016. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from January 1, 2016 through December 31, 2018).

SEC source: 0001645277-17-000001 · edgar.xml · nonDerivative · entry 3

Vibert Paul · CIK 0001645277 · CVP, International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,633

F3 · kind: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2014, 2015 and 2016 as part of the 2014 PSUs.

SEC source: 0001645277-17-000001 · edgar.xml · nonDerivative · entry 2

Vibert Paul · CIK 0001645277 · CVP, International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,802

F2 · kind: Represents shares awarded from the 2014 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Growth in Shareholder Value (GSV) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's GSV during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended.

SEC source: 0001645277-17-000001 · edgar.xml · nonDerivative · entry 1

Vibert Paul · CIK 0001645277 · CVP, International

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,209

F1 · kind: Represents shares awarded from the performance share unit award granted on March 4, 2014 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2014 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Return on Invested Capital (ROIC) performance, as assessed annually over a three-year period. One-third of the ROIC performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's ROIC during the January 1, 2016 to December 31, 2016 performance period. These shares have vested as the relevant three-year performance period January 1, 2014 to December 31, 2016 (the Three-Year Performance Period) has ended.

SEC source: 0001645282-17-000001 · edgar.xml · nonDerivative · entry 4

Schabacker Marcus · CIK 0001645282 · CVP, Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,190

F4 · kind: Represents shares earned from the performance share unit award granted on March 3, 2016 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on the Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2016 to December 31, 2016. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from January 1, 2016 through December 31, 2018).

SEC source: 0001645282-17-000001 · edgar.xml · nonDerivative · entry 3

Schabacker Marcus · CIK 0001645282 · CVP, Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,909

F3 · kind: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2014, 2015 and 2016 as part of the 2014 PSUs.

SEC source: 0001645282-17-000001 · edgar.xml · nonDerivative · entry 2

Schabacker Marcus · CIK 0001645282 · CVP, Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,284

F2 · kind: Represents shares awarded from the 2014 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Growth in Shareholder Value (GSV) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's GSV during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended.

SEC source: 0001645282-17-000001 · edgar.xml · nonDerivative · entry 1

Schabacker Marcus · CIK 0001645282 · CVP, Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,192

F1 · kind: Represents shares awarded from the performance share unit award granted on March 4, 2014 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2014 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Return on Invested Capital (ROIC) performance, as assessed annually over a three-year period. One-third of the ROIC performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's ROIC during the January 1, 2016 to December 31, 2016 performance period. These shares have vested as the relevant three-year performance period January 1, 2014 to December 31, 2016 (the Three-Year Performance Period) has ended.

SEC source: 0001362109-17-000001 · edgar.xml · nonDerivative · entry 4

Mason Jeanne K · CIK 0001362109 · CVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,507

F4 · kind: Represents shares earned from the performance share unit award granted on March 3, 2016 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on the Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2016 to December 31, 2016. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from January 1, 2016 through December 31, 2018).

SEC source: 0001362109-17-000001 · edgar.xml · nonDerivative · entry 3

Mason Jeanne K · CIK 0001362109 · CVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,005

F3 · kind: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2014, 2015 and 2016 as part of the 2014 PSUs.

SEC source: 0001362109-17-000001 · edgar.xml · nonDerivative · entry 2

Mason Jeanne K · CIK 0001362109 · CVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,457

F2 · kind: Represents shares awarded from the 2014 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Growth in Shareholder Value (GSV) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's GSV during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended.

SEC source: 0001362109-17-000001 · edgar.xml · nonDerivative · entry 1

Mason Jeanne K · CIK 0001362109 · CVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,360

F1 · kind: Represents shares awarded from the performance share unit award granted on March 4, 2014 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2014 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Return on Invested Capital (ROIC) performance, as assessed annually over a three-year period. One-third of the ROIC performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's ROIC during the January 1, 2016 to December 31, 2016 performance period. These shares have vested as the relevant three-year performance period January 1, 2014 to December 31, 2016 (the Three-Year Performance Period) has ended.

SEC source: 0001645572-17-000001 · edgar.xml · nonDerivative · entry 4

Eyre Brik V · CIK 0001645572 · CVP, Hospital Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,653

F4 · kind: Represents shares earned from the performance share unit award granted on March 3, 2016 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on the Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2016 to December 31, 2016. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from January 1, 2016 through December 31, 2018).

SEC source: 0001645572-17-000001 · edgar.xml · nonDerivative · entry 3

Eyre Brik V · CIK 0001645572 · CVP, Hospital Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,401

F3 · kind: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2014, 2015 and 2016 as part of the 2014 PSUs.

SEC source: 0001645572-17-000001 · edgar.xml · nonDerivative · entry 2

Eyre Brik V · CIK 0001645572 · CVP, Hospital Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,173

F2 · kind: Represents shares awarded from the 2014 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Growth in Shareholder Value (GSV) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's GSV during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended.

SEC source: 0001645572-17-000001 · edgar.xml · nonDerivative · entry 1

Eyre Brik V · CIK 0001645572 · CVP, Hospital Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,475

F1 · kind: Represents shares awarded from the performance share unit award granted on March 4, 2014 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2014 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Return on Invested Capital (ROIC) performance, as assessed annually over a three-year period. One-third of the ROIC performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's ROIC during the January 1, 2016 to December 31, 2016 performance period. These shares have vested as the relevant three-year performance period January 1, 2014 to December 31, 2016 (the Three-Year Performance Period) has ended.

SEC source: 0001593636-17-000001 · edgar.xml · nonDerivative · entry 1

SACCARO JAMES · CIK 0001593636 · CVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,958

F1 · kind: Represents shares earned from the performance share unit award granted on March 3, 2016 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date. The award provides that fifty percent of the performance share units are earned based on the Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2016 to December 31, 2016. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from January 1, 2016 through December 31, 2018).

SEC source: 0001471608-17-000001 · edgar.xml · nonDerivative · entry 4

Scharf David P. · CIK 0001471608 · CVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,789

F4 · kind: Represents shares earned from the performance share unit award granted on March 3, 2016 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on the Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2016 to December 31, 2016. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from January 1, 2016 through December 31, 2018).

SEC source: 0001471608-17-000001 · edgar.xml · nonDerivative · entry 3

Scharf David P. · CIK 0001471608 · CVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,087

F3 · kind: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2014, 2015 and 2016 as part of the 2014 PSUs.

SEC source: 0001471608-17-000001 · edgar.xml · nonDerivative · entry 2

Scharf David P. · CIK 0001471608 · CVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,289

F2 · kind: Represents shares awarded from the 2014 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Growth in Shareholder Value (GSV) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's GSV during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended.

SEC source: 0001471608-17-000001 · edgar.xml · nonDerivative · entry 1

Scharf David P. · CIK 0001471608 · CVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,952

F1 · kind: Represents shares awarded from the performance share unit award granted on March 4, 2014 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2014 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Return on Invested Capital (ROIC) performance, as assessed annually over a three-year period. One-third of the ROIC performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's ROIC during the January 1, 2016 to December 31, 2016 performance period. These shares have vested as the relevant three-year performance period January 1, 2014 to December 31, 2016 (the Three-Year Performance Period) has ended.

SEC source: 0001216761-17-000001 · edgar.xml · nonDerivative · entry 1

ALMEIDA JOSE E · CIK 0001216761 · Director · Chairman of the Board and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,326

F1 · kind: Represents shares earned from the performance share unit award granted on March 3, 2016 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date. The award provides that fifty percent of the performance share units are earned based on the Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2016 to December 31, 2016. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from October 28, 2015 through December 31, 2018).

SEC source: 0001678067-17-000001 · edgar.xml · nonDerivative · entry 4

Accogli Giuseppe · CIK 0001678067 · CVP, Renal

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,996

F4 · kind: Represents shares earned from the performance share unit award granted on March 3, 2016 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on the Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2016 to December 31, 2016. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from January 1, 2016 through December 31, 2018).

SEC source: 0001678067-17-000001 · edgar.xml · nonDerivative · entry 3

Accogli Giuseppe · CIK 0001678067 · CVP, Renal

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,966

F3 · kind: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2014, 2015 and 2016 as part of the 2014 PSUs.

SEC source: 0001678067-17-000001 · edgar.xml · nonDerivative · entry 2

Accogli Giuseppe · CIK 0001678067 · CVP, Renal

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,502

F2 · kind: Represents shares awarded from the 2014 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Growth in Shareholder Value (GSV) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's GSV during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended.

SEC source: 0001678067-17-000001 · edgar.xml · nonDerivative · entry 1

Accogli Giuseppe · CIK 0001678067 · CVP, Renal

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,684

F1 · kind: Represents shares awarded from the performance share unit award granted on March 4, 2014 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2014 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Return on Invested Capital (ROIC) performance, as assessed annually over a three-year period. One-third of the ROIC performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's ROIC during the January 1, 2016 to December 31, 2016 performance period. These shares have vested as the relevant three-year performance period January 1, 2014 to December 31, 2016 (the Three-Year Performance Period) has ended.

SEC source: 0001262931-17-000001 · edgar.xml · derivative · entry 3

FORSYTH JOHN D · CIK 0001262931 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $1 par value · 4,280 shares

Expires 2017-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001262931-17-000001 · edgar.xml · nonDerivative · entry 2

FORSYTH JOHN D · CIK 0001262931 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,058

SEC source: 0001262931-17-000001 · edgar.xml · nonDerivative · entry 1

FORSYTH JOHN D · CIK 0001262931 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,338

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001174532-17-000004 · edgar.xml · derivative · entry 2

Oesterle Stephen N. · CIK 0001174532 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,060

Underlying: Common Stock, $1 par value · 1,060 shares

Expires not disclosed

F2 · derivative.exercise_date: The date exercisable is the date of the 2017 annual meeting of stockholders.

F2 · derivative.expiration_date: The date exercisable is the date of the 2017 annual meeting of stockholders.

SEC source: 0001174532-17-000004 · edgar.xml · nonDerivative · entry 1

Oesterle Stephen N. · CIK 0001174532 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 430

F1 · shares: The reporting person received a grant of 430 restricted stock units which are scheduled to vest on the date of the 2017 annual meeting of stockholders.

F1 · price: The reporting person received a grant of 430 restricted stock units which are scheduled to vest on the date of the 2017 annual meeting of stockholders.

SEC source: 0001206256-17-000001 · edgar.xml · derivative · entry 4

Shapazian Carole J · CIK 0001206256 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $1 par value · 4,280 shares

Expires 2017-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001206256-17-000001 · edgar.xml · nonDerivative · entry 2

Shapazian Carole J · CIK 0001206256 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,227

SEC source: 0001206256-17-000001 · edgar.xml · nonDerivative · entry 1

Shapazian Carole J · CIK 0001206256 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,507

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001220966-17-000001 · edgar.xml · derivative · entry 1

GAVIN JAMES R III · CIK 0001220966 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,290

Underlying: Common Stock, $1 par value · 227 shares

Expires not disclosed

F1 · derivative.exercise_price: 1 for 1

F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Director Deferred Compensation Plan to the Baxter Common Stock Fund notional investment alternative.

F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Director Deferred Compensation Plan to the Baxter Common Stock Fund notional investment alternative.

SEC source: 0001360147-17-000001 · edgar.xml · derivative · entry 1

Chen Thomas F · CIK 0001360147 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,810

Underlying: Common Stock, $1 par value · 153 shares

Expires not disclosed

F1 · derivative.exercise_price: 1 for 1

F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Director Deferred Compensation Plan to the Baxter Common Stock Fund notional investment alternative.

F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Director Deferred Compensation Plan to the Baxter Common Stock Fund notional investment alternative.

SEC source: 0001645279-17-000001 · edgar.xml · derivative · entry 1

Felicelli Robert · CIK 0001645279 · CVP, Business Transformation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,502

Underlying: Common Stock Fund, $1 par value · 49 shares

Expires not disclosed

F1 · derivative.exercise_price: 1 for 1

F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan.

F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan.

SEC source: 0001645279-16-000040 · edgar.xml · derivative · entry 1

Felicelli Robert · CIK 0001645279 · CVP, Business Transformation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,507

Underlying: Common Stock, $1 par value · 49 shares

Expires not disclosed

F1 · derivative.exercise_price: 1 for 1

F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan.

F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan.

SEC source: 0001645279-16-000039 · edgar.xml · derivative · entry 1

Felicelli Robert · CIK 0001645279 · CVP, Business Transformation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,369

Underlying: Common Stock, $1 par value · 50 shares

Expires not disclosed

F1 · derivative.exercise_price: 1 for 1

F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan.

F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan.

SEC source: 0001645572-16-000007 · edgar.xml · nonDerivative · entry 2

Eyre Brik V · CIK 0001645572 · CVP, Hospital Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,889

F2 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on December 2, 2013.

SEC source: 0001645572-16-000007 · edgar.xml · nonDerivative · entry 1

Eyre Brik V · CIK 0001645572 · CVP, Hospital Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,184

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock granted on December 2, 2013.

SEC source: 0001228779-16-000005 · edgar.xml · derivative · entry 3

STORM KORNELIS J. · CIK 0001228779 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $1 par value · 4,280 shares

Expires 2017-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001228779-16-000005 · edgar.xml · nonDerivative · entry 2

STORM KORNELIS J. · CIK 0001228779 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,928

F1 · price: All shares sold at $47.10.